BOSTON SCIENTIFIC CORP — Director's Dealing 2025

May 6, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2025-05-02

Reporting Person: Sorenson John Bradley (EVP, Global Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-05-02	Common Stock	M	4204.0000	$0.0000	Acquired	25195.0000	Direct
2025-05-02	Common Stock	F	1918.0000	$104.9300	Disposed	23277.0000	Direct
2025-05-05	Common Stock	S	4572.0000	$104.5400	Disposed	18705.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-05-02	Restricted Stock Units	$	M	4204.0000	Disposed	2026-05-02	Common Stock (4204.0000)	Direct

Footnotes

F1: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 9, 2024.

F3: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 2, 2023, the first anniversary of the date of grant.